Drug
Levocarnitine
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Status Epilepticus | 43 | 22.3 | 22.5 | signal |
| 2 | Seizure | 388 | 19.8 | 22.1 | signal |
| 3 | Generalised Tonic-clonic Seizure | 37 | 13.2 | 13.4 | signal |
| 4 | Epilepsy | 63 | 12.1 | 12.3 | signal |
| 5 | Hepatic Encephalopathy | 19 | 11.9 | 12.0 | signal |
| 6 | Tachypnoea | 27 | 11.7 | 11.7 | signal |
| 7 | Device Related Infection | 28 | 10.6 | 10.7 | signal |
| 8 | Gastroenteritis Viral | 30 | 9.7 | 9.8 | signal |
| 9 | Prescribed Underdose | 33 | 9.7 | 9.8 | signal |
| 10 | Clostridium Difficile Colitis | 16 | 8.8 | 8.9 | signal |
| 11 | Blood Urea Increased | 23 | 8.0 | 8.0 | signal |
| 12 | Pneumonia Aspiration | 34 | 8.0 | 8.0 | signal |
| 13 | Metabolic Acidosis | 40 | 7.4 | 7.5 | signal |
| 14 | Mitral Valve Incompetence | 14 | 7.2 | 7.3 | signal |
| 15 | Spinal Pain | 14 | 7.0 | 7.0 | signal |
| 16 | Neutrophil Count Increased | 12 | 6.8 | 6.8 | signal |
| 17 | Bacteraemia | 13 | 6.5 | 6.5 | signal |
| 18 | Hypotonia | 11 | 6.4 | 6.4 | signal |
| 19 | Malnutrition | 12 | 6.3 | 6.3 | signal |
| 20 | Pulmonary Congestion | 14 | 6.2 | 6.2 | signal |
| 21 | Atelectasis | 10 | 6.0 | 6.0 | signal |
| 22 | Aspiration | 11 | 5.9 | 6.0 | signal |
| 23 | Multiple Organ Dysfunction Syndrome | 27 | 5.7 | 5.7 | signal |
| 24 | Viral Infection | 32 | 5.6 | 5.7 | signal |
| 25 | Gastroenteritis | 14 | 5.6 | 5.6 | signal |
| 26 | Retching | 20 | 5.5 | 5.5 | signal |
| 27 | Prescribed Overdose | 18 | 5.4 | 5.5 | signal |
| 28 | Altered State Of Consciousness | 19 | 5.2 | 5.2 | signal |
| 29 | Obesity | 14 | 5.1 | 5.1 | signal |
| 30 | Shock | 20 | 5.1 | 5.1 | signal |
| 31 | Iron Deficiency Anaemia | 8 | 5.1 | 5.1 | signal |
| 32 | Hypophagia | 22 | 5.1 | 5.1 | signal |
| 33 | Hepatic Failure | 26 | 5.0 | 5.1 | signal |
| 34 | Encephalopathy | 21 | 5.0 | 5.0 | signal |
| 35 | Grand Mal Convulsion | 8 | 5.0 | 5.0 | signal |
| 36 | Acute Respiratory Distress Syndrome | 15 | 5.0 | 5.0 | signal |
| 37 | Sinus Tachycardia | 12 | 5.0 | 5.0 | signal |
| 38 | Product Prescribing Error | 20 | 4.9 | 5.0 | signal |
| 39 | Myoclonus | 10 | 4.9 | 4.9 | signal |
| 40 | Cholestasis | 16 | 4.9 | 4.9 | signal |
| 41 | Vitamin D Deficiency | 8 | 4.8 | 4.8 | signal |
| 42 | Ileus | 10 | 4.8 | 4.8 | signal |
| 43 | Secretion Discharge | 10 | 4.7 | 4.7 | signal |
| 44 | Hypersomnia | 23 | 4.7 | 4.7 | signal |
| 45 | Coagulopathy | 13 | 4.6 | 4.6 | signal |
| 46 | Respiratory Failure | 57 | 4.6 | 4.6 | signal |
| 47 | Abnormal Behaviour | 31 | 4.5 | 4.6 | signal |
| 48 | Hyperbilirubinaemia | 8 | 4.5 | 4.5 | signal |
| 49 | Blood Bilirubin Increased | 21 | 4.5 | 4.6 | signal |
| 50 | Rhabdomyolysis | 32 | 4.5 | 4.5 | signal |
| 51 | Ear Infection | 20 | 4.4 | 4.4 | signal |
| 52 | Adrenal Insufficiency | 9 | 4.4 | 4.4 | signal |
| 53 | Hypoxia | 26 | 4.3 | 4.4 | signal |
| 54 | Lymphocyte Count Decreased | 13 | 4.3 | 4.3 | signal |
| 55 | Generalised Oedema | 9 | 4.3 | 4.3 | signal |
| 56 | Respiratory Distress | 20 | 4.2 | 4.3 | signal |
| 57 | Hyperglycaemia | 26 | 4.2 | 4.2 | signal |
| 58 | Incorrect Route Of Product Administration | 12 | 4.2 | 4.2 | signal |
| 59 | Product Use Complaint | 11 | 4.1 | 4.2 | signal |
| 60 | Hepatomegaly | 7 | 4.1 | 4.2 | signal |
| 61 | Rebound Effect | 8 | 4.1 | 4.1 | signal |
| 62 | Feeding Disorder | 14 | 4.1 | 4.1 | signal |
| 63 | Blood Potassium Decreased | 21 | 4.1 | 4.1 | signal |
| 64 | Respiratory Tract Infection | 18 | 4.1 | 4.1 | signal |
| 65 | Ascites | 20 | 4.0 | 4.0 | signal |
| 66 | Acute Respiratory Failure | 13 | 4.0 | 4.0 | signal |
| 67 | Respiratory Disorder | 20 | 3.9 | 3.9 | signal |
| 68 | Acute Hepatic Failure | 9 | 3.9 | 3.9 | signal |
| 69 | Hepatic Cytolysis | 8 | 3.8 | 3.8 | signal |
| 70 | Respiratory Depression | 8 | 3.8 | 3.8 | signal |
| 71 | Convulsion | 37 | 3.7 | 3.8 | signal |
| 72 | Sleep Apnoea Syndrome | 12 | 3.7 | 3.7 | signal |
| 73 | Supraventricular Tachycardia | 6 | 3.7 | 3.7 | signal |
| 74 | Lethargy | 36 | 3.7 | 3.7 | signal |
| 75 | Pancreatitis | 33 | 3.6 | 3.7 | signal |
| 76 | Affect Lability | 6 | 3.6 | 3.6 | signal |
| 77 | Aggression | 31 | 3.6 | 3.6 | signal |
| 78 | Blood Creatine Phosphokinase Increased | 18 | 3.6 | 3.6 | signal |
| 79 | Somnolence | 122 | 3.5 | 3.6 | signal |
| 80 | Insurance Issue | 9 | 3.5 | 3.5 | signal |
| 81 | Febrile Neutropenia | 40 | 3.5 | 3.6 | signal |
| 82 | Septic Shock | 26 | 3.5 | 3.5 | signal |
| 83 | Hepatic Function Abnormal | 22 | 3.5 | 3.5 | signal |
| 84 | Bacterial Infection | 11 | 3.5 | 3.5 | signal |
| 85 | Hepatic Cirrhosis | 11 | 3.4 | 3.4 | signal |
| 86 | Initial Insomnia | 6 | 3.4 | 3.4 | signal |
| 87 | Blood Sodium Decreased | 11 | 3.4 | 3.4 | signal |
| 88 | Dyskinesia | 23 | 3.3 | 3.3 | signal |
| 89 | Influenza | 63 | 3.3 | 3.3 | signal |
| 90 | Cardiogenic Shock | 8 | 3.3 | 3.3 | signal |
| 91 | Pharyngitis Streptococcal | 6 | 3.2 | 3.2 | signal |
| 92 | Infusion Site Pain | 7 | 3.2 | 3.2 | signal |
| 93 | Irritability | 33 | 3.2 | 3.2 | signal |
| 94 | Psychomotor Hyperactivity | 9 | 3.2 | 3.2 | signal |
| 95 | Appendicitis | 5 | 3.1 | 3.1 | signal |
| 96 | Skin Infection | 6 | 3.1 | 3.1 | signal |
| 97 | Sedation | 14 | 3.1 | 3.1 | signal |
| 98 | Personality Change | 5 | 3.1 | 3.1 | signal |
| 99 | Hospitalisation | 81 | 3.1 | 3.2 | signal |
| 100 | Peritonitis | 11 | 3.1 | 3.1 | signal |
| 101 | Hypocalcaemia | 10 | 3.1 | 3.1 | signal |
| 102 | Agitation | 39 | 3.1 | 3.1 | signal |
| 103 | Therapy Change | 5 | 3.0 | 3.0 | signal |
| 104 | Femur Fracture | 16 | 3.0 | 3.0 | signal |
| 105 | Eating Disorder | 11 | 3.0 | 3.0 | signal |
| 106 | Poor Quality Sleep | 11 | 3.0 | 3.0 | signal |
| 107 | Splenomegaly | 6 | 3.0 | 3.0 | signal |
| 108 | Underdose | 37 | 3.0 | 3.0 | signal |
| 109 | Pancytopenia | 28 | 2.9 | 3.0 | signal |
| 110 | Blood Lactate Dehydrogenase Increased | 8 | 2.9 | 2.9 | signal |
| 111 | Electrocardiogram Qt Prolonged | 18 | 2.9 | 2.9 | signal |
| 112 | Hypothermia | 5 | 2.9 | 2.9 | signal |
| 113 | Hepatocellular Injury | 7 | 2.9 | 2.9 | signal |
| 114 | Hyperthyroidism | 7 | 2.8 | 2.8 | signal |
| 115 | Drug Level Increased | 8 | 2.8 | 2.8 | signal |
| 116 | Jaundice | 13 | 2.8 | 2.8 | signal |
| 117 | Depressed Level Of Consciousness | 19 | 2.8 | 2.8 | signal |
| 118 | Proteinuria | 9 | 2.8 | 2.8 | signal |
| 119 | Therapy Partial Responder | 7 | 2.7 | 2.7 | signal |
| 120 | Product Dose Omission Issue | 132 | 2.7 | 2.8 | signal |
| 121 | Cardiac Arrest | 38 | 2.7 | 2.7 | signal |
| 122 | International Normalised Ratio Increased | 13 | 2.6 | 2.6 | signal |
| 123 | Nervous System Disorder | 14 | 2.6 | 2.6 | signal |
| 124 | Restlessness | 16 | 2.6 | 2.6 | signal |
| 125 | Covid-19 | 77 | 2.5 | 2.6 | signal |
| 126 | Blood Test Abnormal | 6 | 2.5 | 2.5 | no signal |
| 127 | Increased Appetite | 8 | 2.5 | 2.5 | signal |
| 128 | Posterior Reversible Encephalopathy Syndrome | 4 | 2.5 | 2.5 | no signal |
| 129 | Illness | 42 | 2.4 | 2.5 | signal |
| 130 | Thrombotic Microangiopathy | 4 | 2.4 | 2.4 | no signal |
| 131 | Lactic Acidosis | 13 | 2.4 | 2.4 | signal |
| 132 | Salivary Hypersecretion | 4 | 2.3 | 2.3 | no signal |
| 133 | Respiratory Arrest | 11 | 2.3 | 2.3 | signal |
| 134 | Blood Triglycerides Increased | 7 | 2.3 | 2.3 | no signal |
| 135 | Surgery | 22 | 2.2 | 2.2 | signal |
| 136 | Full Blood Count Abnormal | 4 | 2.2 | 2.2 | no signal |
| 137 | Complication Associated With Device | 5 | 2.2 | 2.2 | no signal |
| 138 | Frequent Bowel Movements | 10 | 2.2 | 2.2 | signal |
| 139 | Mood Altered | 10 | 2.2 | 2.2 | signal |
| 140 | Product Dispensing Error | 8 | 2.2 | 2.2 | no signal |
| 141 | Intentional Dose Omission | 10 | 2.1 | 2.1 | signal |
| 142 | Therapeutic Response Decreased | 22 | 2.1 | 2.1 | signal |
| 143 | Device Occlusion | 5 | 2.1 | 2.1 | no signal |
| 144 | Eye Irritation | 20 | 2.1 | 2.1 | signal |
| 145 | Anger | 12 | 2.1 | 2.1 | signal |
| 146 | Bone Marrow Failure | 7 | 2.0 | 2.0 | no signal |
| 147 | Multi-organ Failure | 6 | 2.0 | 2.0 | no signal |
| 148 | Laboratory Test Abnormal | 10 | 2.0 | 2.0 | no signal |
| 149 | Muscle Spasticity | 4 | 1.9 | 1.9 | no signal |
| 150 | Abortion Induced | 3 | 1.9 | 1.9 | no signal |
| 151 | Parkinsonism | 3 | 1.8 | 1.8 | no signal |
| 152 | Drug Level Decreased | 3 | 1.7 | 1.7 | no signal |
| 153 | Product Odour Abnormal | 3 | 1.7 | 1.7 | no signal |
| 154 | Diabetes Mellitus Inadequate Control | 5 | 1.7 | 1.7 | no signal |
| 155 | Pulmonary Arterial Hypertension | 4 | 1.6 | 1.6 | no signal |
| 156 | Application Site Pain | 6 | 1.6 | 1.6 | no signal |
| 157 | Overdose | 55 | 1.5 | 1.5 | no signal |
| 158 | Cytomegalovirus Infection | 4 | 1.4 | 1.4 | no signal |
| 159 | Anorexia | 3 | 1.3 | 1.3 | no signal |
| 160 | Device Breakage | 9 | 1.3 | 1.3 | no signal |
| 161 | Product Dose Omission | 14 | 1.2 | 1.2 | no signal |
| 162 | Diabetic Ketoacidosis | 5 | 1.2 | 1.2 | no signal |
| 163 | Product Preparation Error | 4 | 1.1 | 1.1 | no signal |
| 164 | Product Substitution Issue | 11 | 1.1 | 1.1 | no signal |
| 165 | Device Issue | 11 | 0.7 | 0.7 | no signal |
| 166 | Tardive Dyskinesia | 3 | 0.6 | 0.6 | no signal |
| 167 | Drug Dose Omission By Device | 8 | 0.6 | 0.6 | no signal |
| 168 | Device Leakage | 4 | 0.6 | 0.6 | no signal |